OTLK Outlook Therapeutics, Inc.: institutional ownership and insider trading
72 funds reported holding $35.9M of Outlook Therapeutics, Inc. in their latest 13F filings; in Q2 2026 funds net bought $16.8M, with 25 new positions and 13 funds selling out; over the last 12 months insiders bought $7.91M and sold $0 on the open market.
Famous investors holding OTLK
- Ken Griffin (Citadel Advisors): $626K, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $92.0K, 0.0% of the portfolio
Largest institutional holders of OTLK
- VANGUARD CAPITAL MANAGEMENT LLC — $6.96M
- PERCEPTIVE ADVISORS LLC — $4.99M
- MARSHALL WACE, LLP — $3.16M
- SUSQUEHANNA INTERNATIONAL GROUP, LLP — $2.69M
- BlackRock, Inc. (BLK) — $2.65M
- JANE STREET GROUP, LLC — $2.64M
- VANGUARD GROUP INC — $2.31M
- GEODE CAPITAL MANAGEMENT, LLC — $1.98M
- HRT FINANCIAL LP — $1.25M
- VANGUARD FIDUCIARY TRUST CO — $1.05M
Recent OTLK insider trades
- Aug 14, 2026: Jahr Robert Charles bought 151,515 shares ($0)
- Aug 14, 2026: Kenyon Lawrence A bought 101,010 shares ($0)
- Aug 12, 2026: Sukhtian Ghiath M. bought 2,525,252 shares ($2.50M)
- Jul 29, 2026: Sukhtian Faisal Ghiath bought 95,398 shares ($100K)
5%+ owners
- GMS Ventures & Investments: 16.4% (Schedule 13D/A, filed Aug 14, 2026)
- CVI Investments, Inc.: 9.9% (Schedule 13G, filed Aug 19, 2026)
- Empery Asset Management, LP: 8.7% (Schedule 13G, filed Oct 13, 2026)